VRH Annual Meeting January 18, 2022 Video Recording

Annual Meeting of the Valley Regional Healthcare Assembly of Overseers, and Valley Regional Healthcare and Hospital Corporations

Meeting Agenda

5:15 PM Start Logging into Zoom Webinar (link to webinar has been emailed to individuals in our guest list)

5:30 PM Meeting of the VRH Overseers

  • Welcome – Bryan Huot
  • Approve Minutes of January 19, 2021
  • Governance Committee Report – Bryan Huot
  • Reappoint to Board of Trustees 3-year Term (2022 – 2025)
    • James Borchert, Bryan Huot, Scott Bouranis, Patricia Putnam, Eric Crainich, Lisa Richmond, Alex Scott, Gailyn Thomas, MD
  • Reappoint to the Assembly of Overseers 5-year Term (2022 – 2027)
    • Matt Blanc, Roz Caplan, George Grabe, DMD, Reginald Greene, Alexander Herzog, Bernard Rosen, MD, Mike Satzow, Robert Sprano, Carol Vivian, James Borchert, Patricia Putnam, Tom Sullivan
  • Appoint to the Assembly of Overseers 5-year Term (2022 – 2027)
    • Cynthia Burr, Terri Decker, Katherine LaJoie

5:45 PM Public Meeting

  • Welcome – Bryan Huot
  • Financial Report – Lisa Richmond, Treasurer & Jean Shaw, CFO
  • Operations Report – Jocelyn Caple, President and CEO
  • Guest Speaker – Dr. Michael S. Calderwood

7:00 PM Adjournment

Please reach out to Savannah Tyrrell via email (savannah.tyrrell@vrh.org)  if you have trouble logging on. 

We’re pleased to announce this year’s guest speaker is Dr. Michael S. Calderwood.

Dr. Michael S. Calderwood

Michael S. Calderwood, MD, MPH

Dr. Calderwood was named Chief Quality Officer of DHMC in February 2021. He had served as Associate Chief Quality Officer for D-H since 2019. As Chief Quality Officer for DHMC, his responsibilities include management and oversight of the integration of safety, quality, patient experience and value/process improvement activities, along with oversight of quality assurance and regulatory compliance. In addition, he works closely with other D-H chief officers to identify organizational quality, safety, patient experience and value opportunities annually and develop policies, programs, metrics, reporting and accountability to aggressively implement improvement.

Dr. Calderwood earned a bachelor’s degree in Biology from Harvard followed by a medical degree from the University of Chicago Pritzker School of Medicine. He completed his residency in Internal Medicine at Brigham and Women’s Hospital and a fellowship in Infectious Diseases in the combined Brigham and Women’s Hospital/Massachusetts General Hospital program in Boston. He also holds a master’s of public health degree from the Harvard School of Public Health.

Dr. Calderwood started his career on staff at Brigham and Women’s Hospital where he directed the hospital’s antimicrobial stewardship program, was one of the hospital epidemiologists, and was a research investigator in the Therapeutic Research and Infectious Disease Epidemiology group in the Harvard Medical School Department of Population Medicine. This research involved collaborations with the Centers for Disease Control and Prevention, the Centers for Medicare & Medicaid Services, and the Agency for Healthcare Research and Quality.

Dr. Calderwood joined Dartmouth-Hitchcock in 2016, and is an Associate Professor of Medicine at the Geisel School of Medicine at Dartmouth. He is an active physician in the Section of Infectious Disease and International Health, and is board certified in Internal Medicine and Infectious Disease. Prior to his current leadership role, he served as Regional Hospital Epidemiologist for the Dartmouth-Hitchcock Health system, as the Medical Co-director of the Collaborative Healthcare-associated Infection Prevention (CHIP) team, and as one of the leaders of the DHMC Comprehensive Antimicrobial Program. He continues to serve as Co-chair the D-H Quality Committee, SEARCHES (Significant Event Analysis of Root Causes and Hospital Systems) and the System Pharmacy & Therapeutics Committee.

Dr. Calderwood was elected a fellow of the Infectious Diseases Society of America, is a member of the Society for Healthcare Epidemiology of America, and has served on a number of committees and workgroups in both organizations. He is also active in a number of state advisory workgroups and has been actively engaged in the D-HH system response to the COVID-19 pandemic.